Securities fraud litigation history and active cases
In Litigation
0
Settlement
1
Closed
1
Total Settlement
$44M
2:18cv17645 • December 27, 2018
Class Period Start
February 8, 2018
Class Period End
April 17, 2019
PSLRA Deadline
February 25, 2019
Case Allegations
10b5
Statutes of Repose
Feb 8, 2021
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
June 8, 2023
Settlement Fund
$40,000,000
Settlement Status
Final Approval
Settlement Class
All persons or entities that purchased or otherwise acquired Immunomedics common stock during the period between February 9, 2018 and January 17, 2019, inclusive.
Claim Administrator
JND Legal Administration
Immunomedics Securities Settlement
Claims Administrator
c/o JND Legal Administration
P.O. Box 91456
Seattle, WA 98111
+1 855-678-0183
[email protected]
Settlement Website
https://www.immunomedicssecuritiessettlement.com/Hearing Date
June 15, 2019
Opt-out Deadline
May 25, 2023
Settlement Note
Download hereProof Of Claim
Download here
Jun 15, 2023
Final Approval of Settlement
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Feb 23, 2023
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Feb 22, 2023
Proof of Claim Form
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Jan 20, 2023
Proposed Settlement
Jun 2, 2022
Motion for Class Certification
The plaintiffs have asked the court to approve the lawsuit to proceed as a class action on behalf of a group of investors. The judge will decide whether the case meets the requirements for class certification and which investors and claims may be included.
2:16cv3335 • June 9, 2016
Class Period Start
May 1, 2016
Class Period End
September 23, 2016
PSLRA Deadline
August 8, 2016
Case Allegations
10b5
Statutes of Repose
May 1, 2019
Country
United States
Court
Federal Court
Please note that for cases in the settlement stage, claims are handled by the claims administrator and NOT Levi & Korsinsky. Any information or documentation previously provided to us does not constitute submission of a claim. If you need to file a claim, check the status of a claim, or have questions regarding distribution of settlement funds, please contact the claims administrator below.
Claim Deadline
December 6, 2022
Settlement Fund
$4,000,000
Settlement Status
Disbursed
Settlement Class
All persons or entities that purchased the publicly traded securities of Immunomedics, Inc. (“Immunomedics”) from May 2, 2016, through June 24, 2016, both dates inclusive.
Claim Administrator
Strategic Claims Services
Immunomedics, Inc. Securities Litigation
c/o Strategic Claims Services
600 N. Jackson St., Ste. 205
P.O. Box 230
Media, PA 19063
+1 400-4__-____
[email protected]
Settlement Website
www.strategicclaims.net/Immunomedics/Hearing Date
January 19, 2023
Opt-out Deadline
December 29, 2022
Settlement Note
Download hereProof Of Claim
Download here
May 30, 2023
Disbursement Approved
The court has approved the distribution of settlement funds to eligible class members. Investors with approved claims may receive payments from the settlement. If you have questions about your claim or payment, contact the claims administrator.
Jan 19, 2023
Final Approval of Settlement
The court has granted final approval of the settlement. Eligible investors who submit valid claims may receive a payment once the claims review and distribution process is completed.
Oct 5, 2022
Proof of Claim Form
To receive your portion of the recovery (if you are eligible), you must submit this form to the claims administrator by the deadline indicated on the form itself. If you do not submit this form in time, you will not be entitled to compensation. If you have questions about how to complete the form, you should contact the claims administrator.
Oct 5, 2022
Preliminary Approval of Settlement
The court has granted preliminary approval of a proposed settlement. This means the settlement can move forward for further consideration, but it has not yet received final approval. Potential class members will generally receive notice explaining the settlement, their rights, and any deadlines for submitting a claim, objecting to the settlement, or choosing not to participate.
Apr 14, 2022
Proposed Settlement
TOP
